Lineage Cell TherapeuticsLCTX 
$0.88-3.30%24h
-3.30%24h
Global rank
Market cap$153.99M
Change 7d0.00%
YTD Performance-19.27%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Lineage Cell Therapeutics (LCTX)
As of December 2024, Lineage Cell Therapeutics has a market cap of $153.99M. This makes Lineage Cell Therapeutics the world's th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Lineage Cell Therapeutics from 1992 to 2024
-
Value:-
Market cap history of Lineage Cell Therapeutics from 1992 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $181.99M | -4.59% |
| 2023 | $190.74M | -6.84% |
| 2022 | $204.73M | -52.24% |
| 2021 | $428.72M | 39.20% |
| 2020 | $307.98M | 97.75% |
| 2019 | $155.74M | -2.20% |
| 2018 | $159.24M | -57.67% |
| 2017 | $376.22M | -40.44% |
| 2016 | $631.70M | -11.95% |
| 2015 | $717.45M | 9.92% |
| 2014 | $652.70M | 3.61% |
| 2013 | $629.95M | 14.65% |
| 2012 | $549.46M | -45.96% |
| 2011 | $1.02B | -30.25% |
| 2010 | $1.46B | 96.93% |
| 2009 | $740.20M | 138.98% |
| 2008 | $309.73M | 331.71% |
| 2007 | $71.74M | 51.85% |
| 2006 | $47.25M | -12.90% |
| 2005 | $54.25M | -79.47% |
| 2004 | $264.23M | 9.42% |
| 2003 | $241.48M | -10.97% |
| 2002 | $271.23M | -66.30% |
| 2001 | $804.94M | -38.67% |
| 2000 | $1.31B | -15.49% |
| 1999 | $1.55B | -48.92% |
| 1998 | $3.04B | -8.55% |
| 1997 | $3.32B | 103.57% |
| 1996 | $1.63B | 796.00% |
| 1995 | $182.28M | 56.25% |
| 1994 | $116.66M | -74.60% |
| 1993 | $459.34M | -19.23% |
| 1992 | $568.71M | - |
LCTX Market Cap Today is $153.99M -3.30% - 12 Dec 2024
View largest stocks by market cap 
